Position in ALKS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,148
+$699 QoQ
Shares Held
41
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#377
of 421 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Godfrey Financial Associates, Inc. holds $224,352 across 13 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,225 | $206,461 | |
| 2 | VTRS |
Viatris Inc
|
372 | $5,907 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
21 | $2,329 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
131 | $2,267 | |
| 5 | ALKS |
Alkermes plc.
This page
|
41 | $2,148 | |
| 6 | HLN |
Haleon plc
|
207 | $1,931 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
28 | $970 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
26 | $880 |
All Filings in ALKS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,148 | 41 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,449 | 41 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,147 | 41 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||